These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35588735)

  • 1. COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia.
    Parry H; Bruton R; Roberts T; McIlroy G; Damery S; Sylla P; Dowell AC; Tut G; Lancaster T; Bone D; Willett B; Logan N; Scott S; Hulme S; Jadir A; Amin U; Nicol S; Stephens C; Faustini S; Al-Taei S; Richter A; Blakeway D; Verma K; Margielewska-Davies S; Pearce H; Pratt G; Zuo J; Paneesha S; Moss P
    Cancer Cell; 2022 Jun; 40(6):584-586. PubMed ID: 35588735
    [No Abstract]   [Full Text] [Related]  

  • 2. mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis.
    Molica S; Giannarelli D; Montserrat E
    Eur J Haematol; 2022 Mar; 108(3):264-267. PubMed ID: 34856031
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the BTN162b2 mRNA COVID-19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia.
    Fiorcari S; Atene CG; Maffei R; Mesini N; Debbia G; Colasante C; Pozzi S; Barbieri E; Maccaferri M; Leonardi G; Potenza L; Luppi M; Marasca R
    Hematol Oncol; 2023 Feb; 41(1):120-127. PubMed ID: 36156278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
    Morawska M
    Eur J Haematol; 2022 Feb; 108(2):91-98. PubMed ID: 34717004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia.
    Mellinghoff SC; Mayer L; Robrecht S; Weskamm LM; Dahlke C; Gruell H; Schlotz M; Vanshylla K; Schloser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
    Haematologica; 2022 Oct; 107(10):2480-2484. PubMed ID: 35734927
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
    Del Poeta G; Bomben R; Polesel J; Rossi FM; Pozzo F; Zaina E; Cattarossi I; Varaschin P; Nanni P; Boschian Boschin R; Postorino M; Laureana R; Pasqualone G; Steffan A; Gentile M; Zucchetto A; Gattei V
    Hematol Oncol; 2021 Dec; 39(5):712-714. PubMed ID: 34462939
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.
    Lyski ZL; Kim MS; Xthona Lee D; Raué HP; Raghunathan V; Griffin J; Ryan D; Brunton AE; Curlin ME; Slifka MK; Messer WB; Spurgeon SE
    Blood Adv; 2022 Feb; 6(4):1207-1211. PubMed ID: 34872103
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 vaccination in CLL: how often is enough?
    Mellinghoff SC; Cornely OA
    Blood; 2022 Dec; 140(25):2655-2657. PubMed ID: 36548017
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
    Mellinghoff SC; Robrecht S; Mayer L; Weskamm LM; Dahlke C; Gruell H; Vanshylla K; Schlösser HA; Thelen M; Fink AM; Fischer K; Klein F; Addo MM; Eichhorst B; Hallek M; Langerbeins P
    Leukemia; 2022 Feb; 36(2):562-565. PubMed ID: 34937858
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccine response in chronic lymphocytic leukaemia is more than just seroconversion.
    Sun C
    Br J Haematol; 2022 Apr; 197(1):11-12. PubMed ID: 35029303
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia.
    Roeker LE; Knorr DA; Thompson MC; Nivar M; Lebowitz S; Peters N; Deonarine I; Momotaj S; Sharan S; Chanlatte V; Hampton B; Butala L; Amato L; Richford A; Lunkenheimer J; Battiato K; Laudati C; Mato AR
    Leukemia; 2021 Sep; 35(9):2703-2705. PubMed ID: 33986431
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia.
    Komissarov AA; Kislova M; Molodtsov IA; Petrenko AA; Dmitrieva E; Okuneva M; Peshkova IO; Shakirova NT; Potashnikova DM; Tvorogova AV; Ptushkin VV; Efimov GA; Nikitin EA; Vasilieva E
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.
    Sorcini D; De Falco F; Gargaro M; Bozza S; Guarente V; Cardinali V; Stella A; Adamo FM; Silva Barcelos EC; Rompietti C; Dorillo E; Geraci C; Esposito A; Arcaleni R; Capoccia S; Mameli MG; Graziani A; Moretti L; Cipiciani A; Riccardi C; Mencacci A; Fallarino F; Rosati E; Sportoletti P
    Br J Haematol; 2023 Apr; 201(1):45-57. PubMed ID: 36484163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab.
    Bacova B; Kohutova Z; Zubata I; Gaherova L; Kucera P; Heizer T; Mikesova M; Karel T; Novak J
    Clin Exp Med; 2023 Jun; 23(2):371-379. PubMed ID: 35352210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous SARS-CoV-2 vaccinations in patients with B-cell lymphoid malignancies.
    Ujjani C; Greninger AL; Shadman M; Hill JA; Lynch RC; Warren EH; Gopal AK
    Am J Hematol; 2022 Feb; 97(2):E67-E69. PubMed ID: 34807468
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination efficacy in patients with chronic lymphocytic leukemia.
    Wang KY; Shah P; Skavla B; Fayaaz F; Chi J; Rhodes JM
    Leuk Lymphoma; 2023 Jan; 64(1):42-56. PubMed ID: 36270021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience.
    Mehta-Shah N; Bartlett NL; Kahl B; Watkins MP; Dubois A; Schmelzle G; Waqar S; Ballman C; Wan F; Farnsworth CW
    Leuk Lymphoma; 2022 Jul; 63(7):1723-1727. PubMed ID: 35225130
    [No Abstract]   [Full Text] [Related]  

  • 18. Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia.
    Molica S; Tam C; Polliack A
    Hematol Oncol; 2022 Aug; 40(3):313-319. PubMed ID: 35304771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity.
    Shen Y; Freeman JA; Holland J; Solterbeck A; Naidu K; Soosapilla A; Downe P; Tang C; Kerridge I; Wallman L; Van Bilsen N; Milogiannakis V; Akerman A; Martins Costa Gomes G; Sandgren K; Cunningham AL; Turville S; Mulligan SP
    Br J Haematol; 2022 Apr; 197(1):41-51. PubMed ID: 34962656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemia.
    Ujjani C; Shadman M; Lynch RC; Tu B; Stevenson PA; Grainger C; Zhu H; Hill JA; Huang ML; Nielsen L; Poh C; Sorensen T; Gopal AK; Warren EH; Till BG; Lee S; Gausman D; Smith SD; Gooley T; Greninger A
    Br J Haematol; 2022 May; 197(3):306-309. PubMed ID: 35149986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.